ArticleEuropean urology2010

Words of wisdom. Re: Overall survival analysis of a phase II randomized controlled trial of a poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer. Kantoff PW, Schuetz TJ, Blumenstein BA, et al.

David S Finley et al.PubMed ↗Publisher ↗

No numbers read from the abstract.